Skip to main content
Fig. 2 | Infectious Agents and Cancer

Fig. 2

From: Real-world clinical features and survival outcomes in diffuse large B-cell lymphoma patients with hepatitis B virus infection

Fig. 2

Kaplan‒Meier analysis of the OS and PFS in patients with different HBV serologic statuses and different chemotherapy regimens. OS (A) and PFS (B) in patients with different HBV serologic statuses. OS (C) and PFS (D) in patients treated with different chemotherapy regimens. OS: overall survival; PFS: progression-free survival; HBV: hepatitis B virus

Back to article page

Infectious Agents and Cancer

ISSN: 1750-9378

Contact us